Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity.
Efficacy of antitumor vaccination depends to a large extent on antigen targeting to dendritic cells (DCs). Here, we assessed antitumor immunity induced by attenuated coronavirus vectors which exclusively target DCs in vivo and express either lymphocyte- or DC-activating cytokines in combination with...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3842931?pdf=render |
id |
doaj-8e39703a017b4475a1f32c11b84963e9 |
---|---|
record_format |
Article |
spelling |
doaj-8e39703a017b4475a1f32c11b84963e92020-11-25T01:23:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e8144210.1371/journal.pone.0081442Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity.Christian Perez-ShibayamaCristina Gil-CruzMonika NussbacherEva AllgäuerLuisa Cervantes-BarraganRoland ZüstBurkhard LudewigEfficacy of antitumor vaccination depends to a large extent on antigen targeting to dendritic cells (DCs). Here, we assessed antitumor immunity induced by attenuated coronavirus vectors which exclusively target DCs in vivo and express either lymphocyte- or DC-activating cytokines in combination with a GFP-tagged model antigen. Tracking of in vivo transduced DCs revealed that vectors encoding for Fms-like tyrosine kinase 3 ligand (Flt3L) exhibited a higher capacity to induce DC maturation compared to vectors delivering IL-2 or IL-15. Moreover, Flt3L vectors more efficiently induced tumor-specific CD8(+) T cells, expanded the epitope repertoire, and provided both prophylactic and therapeutic tumor immunity. In contrast, IL-2- or IL-15-encoding vectors showed a substantially lower efficacy in CD8(+) T cell priming and failed to protect the host once tumors had been established. Thus, specific in vivo targeting of DCs with coronavirus vectors in conjunction with appropriate conditioning of the microenvironment through Flt3L represents an efficient strategy for the generation of therapeutic antitumor immunity.http://europepmc.org/articles/PMC3842931?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christian Perez-Shibayama Cristina Gil-Cruz Monika Nussbacher Eva Allgäuer Luisa Cervantes-Barragan Roland Züst Burkhard Ludewig |
spellingShingle |
Christian Perez-Shibayama Cristina Gil-Cruz Monika Nussbacher Eva Allgäuer Luisa Cervantes-Barragan Roland Züst Burkhard Ludewig Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity. PLoS ONE |
author_facet |
Christian Perez-Shibayama Cristina Gil-Cruz Monika Nussbacher Eva Allgäuer Luisa Cervantes-Barragan Roland Züst Burkhard Ludewig |
author_sort |
Christian Perez-Shibayama |
title |
Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity. |
title_short |
Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity. |
title_full |
Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity. |
title_fullStr |
Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity. |
title_full_unstemmed |
Dendritic cell-specific delivery of Flt3L by coronavirus vectors secures induction of therapeutic antitumor immunity. |
title_sort |
dendritic cell-specific delivery of flt3l by coronavirus vectors secures induction of therapeutic antitumor immunity. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
Efficacy of antitumor vaccination depends to a large extent on antigen targeting to dendritic cells (DCs). Here, we assessed antitumor immunity induced by attenuated coronavirus vectors which exclusively target DCs in vivo and express either lymphocyte- or DC-activating cytokines in combination with a GFP-tagged model antigen. Tracking of in vivo transduced DCs revealed that vectors encoding for Fms-like tyrosine kinase 3 ligand (Flt3L) exhibited a higher capacity to induce DC maturation compared to vectors delivering IL-2 or IL-15. Moreover, Flt3L vectors more efficiently induced tumor-specific CD8(+) T cells, expanded the epitope repertoire, and provided both prophylactic and therapeutic tumor immunity. In contrast, IL-2- or IL-15-encoding vectors showed a substantially lower efficacy in CD8(+) T cell priming and failed to protect the host once tumors had been established. Thus, specific in vivo targeting of DCs with coronavirus vectors in conjunction with appropriate conditioning of the microenvironment through Flt3L represents an efficient strategy for the generation of therapeutic antitumor immunity. |
url |
http://europepmc.org/articles/PMC3842931?pdf=render |
work_keys_str_mv |
AT christianperezshibayama dendriticcellspecificdeliveryofflt3lbycoronavirusvectorssecuresinductionoftherapeuticantitumorimmunity AT cristinagilcruz dendriticcellspecificdeliveryofflt3lbycoronavirusvectorssecuresinductionoftherapeuticantitumorimmunity AT monikanussbacher dendriticcellspecificdeliveryofflt3lbycoronavirusvectorssecuresinductionoftherapeuticantitumorimmunity AT evaallgauer dendriticcellspecificdeliveryofflt3lbycoronavirusvectorssecuresinductionoftherapeuticantitumorimmunity AT luisacervantesbarragan dendriticcellspecificdeliveryofflt3lbycoronavirusvectorssecuresinductionoftherapeuticantitumorimmunity AT rolandzust dendriticcellspecificdeliveryofflt3lbycoronavirusvectorssecuresinductionoftherapeuticantitumorimmunity AT burkhardludewig dendriticcellspecificdeliveryofflt3lbycoronavirusvectorssecuresinductionoftherapeuticantitumorimmunity |
_version_ |
1725119857262854144 |